Roche antibody cocktail shown effective in COVID-19 patients
- 3 years ago
- Health
New late-stage trial data show Regeneron and Roche’s antibody cocktail against COVID-19 cut hospitalisation or death by 70% versus a placebo
New late-stage trial data show Regeneron and Roche’s antibody cocktail against COVID-19 cut hospitalisation or death by 70% versus a placebo
The three-drug cocktail consists of the HIV medication lopinavir-ritonavir, the hepatitis therapy drug ribavirin and the multiple sclerosis